MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis
Open Access
- 3 January 2019
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 41 (3) , 657-665
Abstract
Background: Recurrent respiratory papillomatosis (RRP) or laryngeal papillomatosis is a disease caused by papillomavirus infection.Methods: In this phase I/II clinical trial, we evaluated the efficacy of the modified vaccinia Ankara (MVA) E2 virus in the treatment of RRP. Twenty‐nine patients (18 female and 11 male) underwent injection of MVA E2 directly into the borders of the vocal cords where lesions were seen and were monitored by direct laryngoscopy. The immune response was assessed by the determination of CD3+, CD4+, and CD8+ lymphocytes counts. The presence of papillomavirus was determined by polymerase chain reaction analysis.Results: Lesions were completely eliminated in 13 patients (44.8%). In 16 patients (55.2%), lesions recurred between 6 and 18 months after treatment; these patients received a second round of treatment with MVA E2, and they are not seen with new recurrences.Conclusion: The MVA E2 vaccine has excellent potential for generating complete regression of RRP lesions.Keywords
Funding Information
- Virolab S de RL de CV
This publication has 37 references indexed in Scilit:
- Effects of conjugated linoleic acid and high oleic acid safflower oil in the treatment of children with HPV-induced laryngeal papillomatosis: a randomized, double-blinded and crossover preliminary studyLipids in Health and Disease, 2012
- Recurrent Respiratory PapillomatosisOtolaryngologic Clinics of North America, 2012
- Partially Randomized, Non-Blinded Trial of DNA and MVA Therapeutic Vaccines Based on Hepatitis B Virus Surface Protein for Chronic HBV InfectionPLOS ONE, 2011
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortiumInternational Journal of Epidemiology, 2009
- Transplacental transmission of Human PapillomavirusVirology Journal, 2008
- Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observationCancer Detection Prevention, 2007
- Recurrent respiratory papillomatosis: an overview of current thinking and treatmentEuropean Archives of Oto-Rhino-Laryngology, 2007
- MVA E2 Recombinant Vaccine in the Treatment of Human Papillomavirus Infection in Men Presenting Intraurethral Flat CondylomaBioDrugs, 2007
- Recurrent respiratory papillomatosisArchives of Disease in Childhood, 2006
- Histopathologic Effects of Cidofovir on CartilageOtolaryngology–Head and Neck Surgery, 2005